Isaac Barchas insider trades: Immunome (IMNM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Isaac reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | IMNM | ↓ Sell | 11,048 | $27.25 | $301K | Direct | Aug 12, 2026 (0d) |
| Aug 11, 2026 | IMNM | ↓ Sell | 72,416 | $26.21 | $1.9M | Indirect | Aug 12, 2026 (1d) |
| Aug 7, 2026 | IMNM | ↓ Sell | 36,088 | $26.06 | $940K | Indirect | Aug 10, 2026 (3d) |
| Jul 7, 2026 | IMNM | ↓ Sell | 100,000 | $24.13 | $2.4M | Indirect | Jul 7, 2026 (0d) |
| Dec 22, 2025 | IMNM | ↓ Sell | 383,200 | $21.74 | $8.3M | Indirect | Dec 23, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMNM insiders
Open-market trades in the last 12 months
About Isaac Barchas's insider trades
Isaac Barchas is an insider at Immunome (IMNM). Since Dec 22, 2025, Isaac has reported no open-market purchases and 5 sales worth $13.9M on SEC Form 4. In the last 12 months: 5 sales ($13.9M).
Their filings also include grants and awards (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMNM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.